Developer docs
API playgroundTry for free, no card

Search company profiles

Biolog-id

Full company profile

uuid0002obp

Namestring
Biolog-id
Legal namestring
Biolog-Id
Websiteurl
biolog-id.com
Company typeenum
Private
Founded yearint
2005
Descriptiontext

Biolog-id is a French private healthcare technology company founded in 2005 and headquartered in Bernay, France, that designs, develops, and markets RFID-based identification and traceability solutions for sensitive therapeutic products across three vertical segments: blood transfusion, plasma fractionation, and injectable chemotherapy. The company's core offering is the patented Biolog-Connect platform and Biolog Data System (BDS) software suite, which combines RFID hardware (tags affixed to each blood unit, encoders, smart storage kits retrofitting existing cabinets, data loggers, mass reading tunnels) with software that converts tag data into real-time actionable information for inventory and traceability from donation to patient administration. Modules such as X-Match (bedside patient-product matching) and the newly launched Smart Access Kit (connected enclosure for remote distribution) extend the platform into patient safety and last-mile distribution.

The company monetizes through three streams: hardware sales of RFID tags (consumed at every blood unit processed) and equipment, software licensing and subscriptions to the BDS suite, and implementation/professional services via a customer care team supporting deployment, training, and integration. Distribution is hybrid: wholly-owned subsidiaries in France, USA (Alpharetta), Spain, Italy, and India (Delhi) handle direct enterprise sales and customer support in core markets, while a network of regional distributors (MedService Sztandar, MP Technologies, EMA, BioEXE, NG Med, PACO SRL, Diamedica, Khalid Scientific, ATC) covers Central/Eastern Europe, the Middle East, South America, and Asia Pacific.

Biolog-id has deployed across 200+ sites in 18 countries, serving more than 100 customers including national blood establishments (Établissement Français du Sang, Scottish National Blood Transfusion Service, Kuwait Central Blood Bank, Instituto Português do Sangue e Transplantação), multi-hospital networks (Hendrick Health, Centro Hospitalar Médio Tejo), and reference transfusion centers (Burgos University Hospital, Centre Hospitalier de la Côte Basque, ARUP Laboratories, The Blood Center of New Orleans). The company holds ISO 9001:2015, ISO 13485:2016, FDA medical device listing, and CE marking. Ownership is concentrated with founder Jean-Claude Mongrenier (Chairman) and majority shareholder Xerys Invest, a French private equity firm whose cumulative stake exceeds $100 million. Ludovic D'Apréa was appointed CEO in July 2025 with a mandate for international growth.

Short descriptiontext

Biolog-id designs and markets patented RFID-based identification and traceability solutions for sensitive therapeutic products, serving blood centers, plasma fractionators, and oncology pharmacies across 18 countries via direct subsidiaries and distributor networks.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersBernay, France
HQ citystring
Bernay
HQ countrystring
France
HQ regionstring
Europe
Markets served

Serves global market

Offices6 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
RFID blood tracking, healthcare traceability solutions, blood bank inventory, medical device identification, plasma fractionation tracking
Industry2 codes
PRIMARYHLAGAEAI
Sample Logistics, Biorepository & IVD Kit Management (Trial Support)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
SECONDARYHLAGAJAH
Sample / Biorepository & Biobank Informatics (Chain-of-Custody)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
NAICS code1 code
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
SIC code1 code
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Healthcare RFID Traceability Solutions
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1RFID Hardware and Consumables
TypeHardware Sales
Description

Sale of RFID tags affixed to blood products, RFID equipment including encoders, smart storage kits, data loggers, and mass reading tunnels. Tags are consumed at each blood unit processed.

biolog-id.com
2Software Licenses and Subscriptions
TypeSubscription Recurring
Description

Biolog Data System (BDS) software suite providing traceability, inventory management, and data analytics. Likely sold as recurring licenses with software updates and support.

biolog-id.com
3Implementation and Professional Services
TypeProfessional Services
Description

Customer care department implements solutions for clients and supports users with training. Field support and integration teams ensure proper solution deployment and ongoing support.

biolog-id.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 6 records shown
1Biolog Transfusion Solution
Description

RFID-based solution for blood products traceability from donation to patient transfusion

biolog-id.com
+5 more records
Core offering1 text field

Biolog-id designs, manufactures and sells RFID-based identification and traceability hardware (RFID tags, encoders, smart storage kits, mass reading tunnels) along with the Biolog Data System (BDS) software platform that delivers real-time inventory management, chain-of-custody tracking, and patient-product matching for sensitive therapeutic products — labile blood products, plasma for fractionation, and injectable chemotherapy — across blood centers, blood banks, hospital transfusion services, plasma fractionators, and hospital pharmacies.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 85% activity coverage with Biolog Oncology solution at Centre Hospitalier de la Côte Basque
+2 more records
Product overview1 text field

Biolog-id offers a modular RFID-based platform consisting of the Biolog Data System (BDS) Software Suite as the core platform, combined with three therapeutic area solutions: Biolog Transfusion (blood products), Biolog Plasma (fractionation), and Biolog Oncology (chemotherapy). The platform includes RFID equipment (encoders, smart storage kits, data loggers, mass reading tunnels), RFID tags, and add-on modules for patient safety (X-Match), and data analytics. Solutions are deployed across blood centers, blood banks, and healthcare establishments globally.

Product and service1 record
1Biolog Transfusion Solution
Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership11 partners
1Advanced Technology Company (ATC)
Strategic tierFlagshipTypeChannel Partner/ Reseller/ DistributorAnnounced on2024-12-15
Description

ATC is the leading distributor of healthcare solutions in Kuwait since 1981. Partnership to implement nationwide blood product tracking across all Kuwait blood centers. ATC manages local implementation and coordination of Biolog-id solution deployment in Middle East region.

biolog-id.com
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2021-07-06
Description

Strategic interoperability partnership enabling Biolog-id RFID technology to integrate with Inlog's Edge Track (Hemo Server) and Edge Blood (CTS Server) software. Combined solution offers enhanced blood product management with better traceability and improved safety.

Strategic tierRegionalTypeChannel Partner/ Reseller/ Distributor
Description

Distributor in Poland for healthcare products and services, focusing on innovation and quality products for health service sector.

4MP Technologies
Strategic tierRegionalTypeChannel Partner/ Reseller/ Distributor
Description

Italian distributor founded in 2011 specializing in medical equipment, electromedical devices, consumables, refrigeration systems, and temperature monitoring for healthcare facilities.

biolog-id.com
Strategic tierRegionalTypeChannel Partner/ Reseller/ Distributor
Description

Italian company supplying and developing healthcare products for blood banks and laboratories, established in 2010 with 25 years of transfusion medicine experience.

6BioEXE
Strategic tierRegionalTypeChannel Partner/ Reseller/ Distributor
Description

Italian company specializing in advanced technology for hospital sector and biological research, serving transfusion centers, hematology labs, and clinical chemistry laboratories.

biolog-id.com
7NG Med
Strategic tierRegionalTypeChannel Partner/ Reseller/ Distributor
Description

Italian company developing technological solutions in Transfusion Medicine, Pain Therapy, and Regenerative Medicine. ISO9001:2015 certified company.

biolog-id.com
Strategic tierRegionalTypeChannel Partner/ Reseller/ Distributor
Description

Italian distributor founded in 1979 operating in transfusion medicine, hematology, cryobiology, medical refrigeration, and oncology specialties.

Strategic tierRegionalTypeChannel Partner/ Reseller/ Distributor
Description

Italian company operating since 1996 providing products and services to transfusion centers, laboratories, and medical departments in Sicily.

Strategic tierRegionalTypeChannel Partner/ Reseller/ Distributor
Description

Established in 1979 in Middle East providing medical, laboratory and pharmaceutical solutions with innovative products and highest quality services.

Strategic tierCoreTypeTechnology or Integration
Description

Partnership with MAK-SYSTEM for integration of Biolog-id RFID devices with SNBTS IT transfusion management solution, enabling real-time visibility of blood components.

Recent move11 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
1Haemonetics Corporation
TypeDirect peer
Description

Haemonetics is the dominant global vendor of blood component management hardware and software, serving the same blood center, blood bank, and plasma fractionator customer base as Biolog-id. Its blood management IT and plasma software products compete directly with Biolog's Biolog Data System suite.

TypeDirect peer
Description

Terumo BCT is a leading supplier of blood component collection, processing, and storage systems globally, addressing the same blood center and hospital transfusion customers as Biolog-id. Its automated blood processing and tracking solutions overlap with Biolog's transfusion and plasma modules.

TypeBroad incumbent
Description

Fresenius Kabi provides a broad portfolio of transfusion medicine products, including blood collection sets, devices, and software for blood banks and hospitals. It competes with Biolog-id across European hospital pharmacy and blood banking segments as an established incumbent.

TypeBroad incumbent
Description

Grifols is a global leader in plasma collection and fractionation, operating a large network of plasma centers with internal traceability systems. It overlaps with Biolog-id's Plasma solution and serves the same fractionator and plasma center buyers.

TypeDirect peer
Description

Azenta provides sample management, biorepository informatics, and RFID-based tracking solutions for biological samples, directly comparable to Biolog-id's Biolog Data System and chain-of-custody capabilities for blood and plasma.

TypeDirect peer
Description

MAK-SYSTEM provides e-TRACELINE, a blood bank and transfusion management IT platform used by national blood services such as SNBTS. It is both an integration partner of Biolog-id and a competitor in the blood bank software category.

7Inlog
TypeDirect peer
Description

Inlog supplies Edge Track and Edge Blood software suites used by European blood centers for donor and transfusion management. Biolog-id has an interoperability partnership with Inlog, but the two compete for the same blood center and hospital IT budget.

TypeBroad incumbent
Description

Terumo's broader medical device portfolio (including BCT and hospital systems) competes in transfusion medicine globally and overlaps with Biolog-id's blood bank and oncology workflows.

9BloodHub
TypeEmerging player
Description

BloodHub is a US-focused blood bank software and inventory management provider serving hospital transfusion services and blood centers. It addresses the same operational pain points (real-time inventory, traceability) targeted by Biolog-id's BDS software.

TypeEmerging player
Description

Terso Solutions specializes in RFID-enabled inventory management for biorepositories, laboratories, and healthcare, overlapping with Biolog-id's RFID tags, smart storage, and sample/biorepository tracking solutions.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers12 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration2 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles10 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries4 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Biolog-id

Healthcare RFID Traceability Solutionsbiolog-id.com

Biolog-id designs and markets patented RFID-based identification and traceability solutions for sensitive therapeutic products, serving blood centers, plasma fractionators, and oncology pharmacies across 18 countries via direct subsidiaries and distributor networks.

What Biolog-id does

Biolog-id is a French private healthcare technology company founded in 2005 and headquartered in Bernay, France, that designs, develops, and markets RFID-based identification and traceability solutions for sensitive therapeutic products across three vertical segments: blood transfusion, plasma fractionation, and injectable chemotherapy. The company's core offering is the patented Biolog-Connect platform and Biolog Data System (BDS) software suite, which combines RFID hardware (tags affixed to each blood unit, encoders, smart storage kits retrofitting existing cabinets, data loggers, mass reading tunnels) with software that converts tag data into real-time actionable information for inventory and traceability from donation to patient administration. Modules such as X-Match (bedside patient-product matching) and the newly launched Smart Access Kit (connected enclosure for remote distribution) extend the platform into patient safety and last-mile distribution.

The company monetizes through three streams: hardware sales of RFID tags (consumed at every blood unit processed) and equipment, software licensing and subscriptions to the BDS suite, and implementation/professional services via a customer care team supporting deployment, training, and integration. Distribution is hybrid: wholly-owned subsidiaries in France, USA (Alpharetta), Spain, Italy, and India (Delhi) handle direct enterprise sales and customer support in core markets, while a network of regional distributors (MedService Sztandar, MP Technologies, EMA, BioEXE, NG Med, PACO SRL, Diamedica, Khalid Scientific, ATC) covers Central/Eastern Europe, the Middle East, South America, and Asia Pacific.

Biolog-id has deployed across 200+ sites in 18 countries, serving more than 100 customers including national blood establishments (Établissement Français du Sang, Scottish National Blood Transfusion Service, Kuwait Central Blood Bank, Instituto Português do Sangue e Transplantação), multi-hospital networks (Hendrick Health, Centro Hospitalar Médio Tejo), and reference transfusion centers (Burgos University Hospital, Centre Hospitalier de la Côte Basque, ARUP Laboratories, The Blood Center of New Orleans). The company holds ISO 9001:2015, ISO 13485:2016, FDA medical device listing, and CE marking. Ownership is concentrated with founder Jean-Claude Mongrenier (Chairman) and majority shareholder Xerys Invest, a French private equity firm whose cumulative stake exceeds $100 million. Ludovic D'Apréa was appointed CEO in July 2025 with a mandate for international growth.

Biolog-id firmographics

Firmographics
Name
Biolog-id
Legal name
Biolog-Id
Website
https://biolog-id.com
Company type
Private
Founded year
2005
Operating status
Operating
Headcount range
51–100 employees
Short description
Biolog-id designs and markets patented RFID-based identification and traceability solutions for sensitive therapeutic products, serving blood centers, plasma fractionators, and oncology pharmacies across 18 countries via direct subsidiaries and distributor networks.
Ownership category
akta.pro rank

Biolog-id industry classification

Industry
Product category
Healthcare RFID Traceability Solutions
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
SIC
Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro industry
PRIMARYHLAGAEAI
Sample Logistics, Biorepository & IVD Kit Management (Trial Support)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
SECONDARYHLAGAJAH
Sample / Biorepository & Biobank Informatics (Chain-of-Custody)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)

Keywords

  • RFID blood tracking
  • Healthcare traceability solutions
  • Blood bank inventory
  • Medical device identification
  • Plasma fractionation tracking

Where Biolog-id is headquartered

Location

Headquarters

HQ city
Bernay
HQ country
France
HQ region
Europe

Offices6 records

Markets served

Biolog-id business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. RFID Hardware and Consumables: Sale of RFID tags affixed to blood products, RFID equipment including encoders, smart storage kits, data loggers, and mass reading tunnels. Tags are consumed at each blood unit processed.
  2. Software Licenses and Subscriptions: Biolog Data System (BDS) software suite providing traceability, inventory management, and data analytics. Likely sold as recurring licenses with software updates and support.
  3. Implementation and Professional Services: Customer care department implements solutions for clients and supports users with training. Field support and integration teams ensure proper solution deployment and ongoing support.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels4 records

Biolog-id product offering

Product offering

Core offering

Biolog-id designs, manufactures and sells RFID-based identification and traceability hardware (RFID tags, encoders, smart storage kits, mass reading tunnels) along with the Biolog Data System (BDS) software platform that delivers real-time inventory management, chain-of-custody tracking, and patient-product matching for sensitive therapeutic products — labile blood products, plasma for fractionation, and injectable chemotherapy — across blood centers, blood banks, hospital transfusion services, plasma fractionators, and hospital pharmacies.

Product overview

Biolog-id offers a modular RFID-based platform consisting of the Biolog Data System (BDS) Software Suite as the core platform, combined with three therapeutic area solutions: Biolog Transfusion (blood products), Biolog Plasma (fractionation), and Biolog Oncology (chemotherapy). The platform includes RFID equipment (encoders, smart storage kits, data loggers, mass reading tunnels), RFID tags, and add-on modules for patient safety (X-Match), and data analytics. Solutions are deployed across blood centers, blood banks, and healthcare establishments globally.

Differentiator

Problem solved

Functional benefit

Brands

  • Biolog Transfusion Solution: RFID-based solution for blood products traceability from donation to patient transfusion
  • Biolog Plasma Solution
  • Biolog Oncology Solution
  • X-Match
  • Smart Access Kit
  • Biolog Data System (BDS)

Products and services

  • Biolog Transfusion Solution

Quantifiable outcome

  • 85% activity coverage with Biolog Oncology solution at Centre Hospitalier de la Côte Basque
  • +2 more outcomes

Companies that use Biolog-id

Customer profile

Named customers12 records

Segments3 records

Ideal customer profiles3 records

Biolog-id technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration2 records

Feature6 records

Biolog-id partnerships and signals

Strategic signal

Partnerships

Eleven partnerships are on record, tiered flagship, core and regional.

  • Advanced Technology Company (ATC)flagshipChannel Partner/ Reseller/ Distributor · 15 December 2024ATC is the leading distributor of healthcare solutions in Kuwait since 1981. Partnership to implement nationwide blood product tracking across all Kuwait blood centers. ATC manages local implementation and coordination of Biolog-id solution deployment in Middle East region.
  • InlogcoreTechnology or Integration · 6 July 2021Strategic interoperability partnership enabling Biolog-id RFID technology to integrate with Inlog's Edge Track (Hemo Server) and Edge Blood (CTS Server) software. Combined solution offers enhanced blood product management with better traceability and improved safety.
  • MedService SztandarregionalChannel Partner/ Reseller/ DistributorDistributor in Poland for healthcare products and services, focusing on innovation and quality products for health service sector.
  • MP TechnologiesregionalChannel Partner/ Reseller/ DistributorItalian distributor founded in 2011 specializing in medical equipment, electromedical devices, consumables, refrigeration systems, and temperature monitoring for healthcare facilities.
  • EMAregionalChannel Partner/ Reseller/ DistributorItalian company supplying and developing healthcare products for blood banks and laboratories, established in 2010 with 25 years of transfusion medicine experience.
  • BioEXEregionalChannel Partner/ Reseller/ DistributorItalian company specializing in advanced technology for hospital sector and biological research, serving transfusion centers, hematology labs, and clinical chemistry laboratories.
  • NG MedregionalChannel Partner/ Reseller/ DistributorItalian company developing technological solutions in Transfusion Medicine, Pain Therapy, and Regenerative Medicine. ISO9001:2015 certified company.
  • PACO SRLregionalChannel Partner/ Reseller/ DistributorItalian distributor founded in 1979 operating in transfusion medicine, hematology, cryobiology, medical refrigeration, and oncology specialties.
  • DiamedicaregionalChannel Partner/ Reseller/ DistributorItalian company operating since 1996 providing products and services to transfusion centers, laboratories, and medical departments in Sicily.
  • Khalid ScientificregionalChannel Partner/ Reseller/ DistributorEstablished in 1979 in Middle East providing medical, laboratory and pharmaceutical solutions with innovative products and highest quality services.
  • MAK-SYSTEM (e-TRACELINE)coreTechnology or IntegrationPartnership with MAK-SYSTEM for integration of Biolog-id RFID devices with SNBTS IT transfusion management solution, enabling real-time visibility of blood components.

Scale indicators7 records

Recent moves11 records

Expansion highlights6 records

Biolog-id competitors and assessment

Company assessment

Direct peers

  • Haemonetics Corporation: Haemonetics is the dominant global vendor of blood component management hardware and software, serving the same blood center, blood bank, and plasma fractionator customer base as Biolog-id. Its blood management IT and plasma software products compete directly with Biolog's Biolog Data System suite.
  • Terumo BCT: Terumo BCT is a leading supplier of blood component collection, processing, and storage systems globally, addressing the same blood center and hospital transfusion customers as Biolog-id. Its automated blood processing and tracking solutions overlap with Biolog's transfusion and plasma modules.
  • Azenta Life Sciences (formerly Brooks Life Sciences): Azenta provides sample management, biorepository informatics, and RFID-based tracking solutions for biological samples, directly comparable to Biolog-id's Biolog Data System and chain-of-custody capabilities for blood and plasma.
  • MAK-SYSTEM (e-TRACELINE): MAK-SYSTEM provides e-TRACELINE, a blood bank and transfusion management IT platform used by national blood services such as SNBTS. It is both an integration partner of Biolog-id and a competitor in the blood bank software category.
  • Inlog: Inlog supplies Edge Track and Edge Blood software suites used by European blood centers for donor and transfusion management. Biolog-id has an interoperability partnership with Inlog, but the two compete for the same blood center and hospital IT budget.

Broad incumbents

  • Fresenius Kabi: Fresenius Kabi provides a broad portfolio of transfusion medicine products, including blood collection sets, devices, and software for blood banks and hospitals. It competes with Biolog-id across European hospital pharmacy and blood banking segments as an established incumbent.
  • Grifols: Grifols is a global leader in plasma collection and fractionation, operating a large network of plasma centers with internal traceability systems. It overlaps with Biolog-id's Plasma solution and serves the same fractionator and plasma center buyers.
  • Terumo (parent): Terumo's broader medical device portfolio (including BCT and hospital systems) competes in transfusion medicine globally and overlaps with Biolog-id's blood bank and oncology workflows.

Emerging players

  • BloodHub: BloodHub is a US-focused blood bank software and inventory management provider serving hospital transfusion services and blood centers. It addresses the same operational pain points (real-time inventory, traceability) targeted by Biolog-id's BDS software.
  • Terso Solutions: Terso Solutions specializes in RFID-enabled inventory management for biorepositories, laboratories, and healthcare, overlapping with Biolog-id's RFID tags, smart storage, and sample/biorepository tracking solutions.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Biolog-id social profiles

Digital presence

Biolog-id compliance and trust

Trust signal

Compliance3 records

Biolog-id financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Biolog-id leadership team

Management profile

Number of profiles

Profiles10 records

Biolog-id subsidiaries and ownership

Company hierarchy

Subsidiaries4 records

Biolog-id funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Biolog-id M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Biolog-id

What does Biolog-id do?

Biolog-id designs, manufactures and sells RFID-based identification and traceability hardware (RFID tags, encoders, smart storage kits, mass reading tunnels) along with the Biolog Data System (BDS) software platform that delivers real-time inventory management, chain-of-custody tracking, and patient-product matching for sensitive therapeutic products — labile blood products, plasma for fractionation, and injectable chemotherapy — across blood centers, blood banks, hospital transfusion services, plasma fractionators, and hospital pharmacies.

Is Biolog-id a public or private company?

Biolog-id is a private company. It is classified as private equity controlled and is currently operating.

When was Biolog-id founded?

Biolog-id was founded in 2005. It employs 51 to 100 people.

Where is Biolog-id based?

Biolog-id is headquartered in Bernay, France, in the Europe region.

How does Biolog-id make money?

Three revenue lines are on record. RFID Hardware and Consumables are the primary driver. The others are software Licenses and Subscriptions and implementation and Professional Services.

Who are Biolog-id's main competitors?

Direct peers on record are Haemonetics Corporation, Terumo BCT, Azenta Life Sciences (formerly Brooks Life Sciences), MAK-SYSTEM (e-TRACELINE) and Inlog. Broad incumbents are Fresenius Kabi, Grifols and Terumo (parent). Emerging players are BloodHub and Terso Solutions.

Does Biolog-id have an API?

No public API is recorded for Biolog-id.

What industry is Biolog-id in?

Biolog-id's product category is Healthcare RFID Traceability Solutions. Its primary akta.pro industry code is HLAGAEAI, Sample Logistics, Biorepository & IVD Kit Management (Trial Support), with a secondary code of HLAGAJAH, Sample / Biorepository & Biobank Informatics (Chain-of-Custody). Its NAICS code is 334510 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
GlobeNewswireBiolog-id Announces Deployment of itsBiolog-id announced deployment of its value-chain-optimization solution at We Are Blood, an Austin-based nonprofit blood center. The installation covers several PLT incubators and the RBC cold room to capture data across process steps. The solution aims to improve availability, affordability, and quality of blood products.GlobeNewswireBiolog-id Launches an Innovative High-Density (HD) RFIDBiolog-id launched an RFID kit for high-volume red blood cell inventory management, deployed at multiple customer sites. The kit features a flexible mounting system and RFID-friendly bins for full traceability. CEO Troy Hilsenroth sees opportunities to apply the architecture to adjacent healthcare verticals.GlobeNewswireBiolog-id completed phase one of deploying its value-chain optimization solution in a multi-state integrated delivery network in the southeast USABiolog-id completed phase one of deploying its value-chain optimization solution in a North Carolina medical center and level II trauma center. The solution automates manual processes and enhances visibility of blood products. Data from the deployment will guide expansion across additional centers in the multi-state network.GlobeNewswireBiolog-id and Genesis Growth Tech Acquisition Corp. Announce Execution of Business Combination Agreement for Proposed Merger to Create Publicly Listed Digital Health Solutions Company Focused on ValueBiolog-id and Genesis Growth Tech Acquisition Corp. executed a business combination agreement for a merger, with Biolog-id as the surviving company. The transaction values Biolog-id at $312 million, and the combined company will list on Nasdaq under the ticker BGID in the first quarter of 2023.GlobeNewswireBiolog-id and Genesis Growth Tech Acquisition Corp. Announce Execution of Memorandum of Understanding for a Proposed Merger to Create Publicly Listed Digital Health Solutions Company Focused on ValueBiolog-id and Genesis Growth Tech Acquisition Corp. announced a proposed merger, with Biolog-id as the surviving company. The deal values Biolog-id at $312 million, and closing is anticipated in the first quarter of 2023. The combined company will list on Nasdaq under the ticker BGID.GlobeNewswireBiolog-id and Genesis Growth Tech Acquisition Corp. Announce Execution of Memorandum of Understanding for a Proposed Merger to Create Publicly Listed Digital Health Solutions Company Focused on ValueBiolog-id and Genesis Growth Tech Acquisition Corp. announced a memorandum of understanding for a proposed merger, with Biolog-id as the surviving company. The transaction values Biolog-id at $312 million, and closing is anticipated in the first quarter of 2023. The combined company will list on Nasdaq under the ticker BGID.GlobeNewswireExperience Accumulated Over 18 Months in Santarém DistrictThe Hospital Distrital de Santarém's Blood Bank has used Biolog-id's Transfusion Solution and Advanced Analytics Dashboards for 18 months. The system provides real-time and retrospective data on blood product movements, improving inventory visibility and decision-making. The bank reports reduced waste and enhanced service quality.GlobeNewswireThe Biolog-id Solution Implemented at Azienda Sanitaria Locale di Pescara in Italy to Track Blood Products and Plasma for FractionationAzienda Sanitaria Locale di Pescara implemented Biolog-id Transfusion and Plasma Processing solutions across three hospitals in Abruzzo, Italy. The RFID-based systems track blood components and plasma for fractionation, supporting inventory and transportation. The solutions aim to improve transfusion value-chain management and long-term process improvement.GlobeNewswireThe Biolog-id Solution Implemented at Azienda Sanitaria Locale di Pescara in Italy to Track Blood Products and Plasma for FractionationAzienda Sanitaria Locale di Pescara implemented Biolog-id Transfusion and Plasma Processing solutions across three hospitals in Abruzzo, Italy. The RFID-based systems track blood components and plasma for fractionation, supporting inventory and transportation. The solutions aim to improve transfusion value-chain management and long-term process improvement.GlobeNewswireNew Data Demonstrates the Significant Impact of Using theBiolog-id, a digital health solution provider, has been collaborating with Children's National Hospital since June 2021. Data collected show reduced RBC unit wastage, increased use of split/aliquoted units, and decreased tech-time counting units. The company continues developing its Value-Chain Optimization platform.